Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole- resistant Helicobacter pylori

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 3, 1997, Pages 523-527

  Breuer, T ^a   Kim, J G ^b   Gurer, I E ^a   Graham, D P ^a   Osato, M ^a   Genta, R M ^a   Graham, D Y ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Korea University College of Medicine   (South Korea)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONSTIPATION; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DUODENUM ULCER; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; RASH; SMOKING; STOMACH BIOPSY; STOMACH PAIN; STOMACH ULCER; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0030853464     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00173.x     Document Type: Article

References (37)

1. Börsch GM, Graham DY. Helicobacter pylori. In: Collen MJ, Benjamin SB, eds. Pharmacology of Peptic Ulcer Disease. Handbook of Experimental Pharmacology, Vol. 99, Berlin: Springer-Verlag, 1991: 107-48.
2. Graham DY, Börsch GMA. The who's and when's of therapy for helicobacter pylori. Am J Gastroenterol 1990; 85: 1552-5.
3. van der Hulst RWM, Keller JJ, Rauws EA, Tytgat GNJ. Treatment of helicobacter pylori infection in humans: a review of the world literature. Helicobacter 1996; 1: 6-19.
4. Bell GD, Bate CM, Axon ATR, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind randomized trial. Aliment Pharmacol Ther 1995; 9: 513-20.
5. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
6. Graham DY. Determinants of antimicrobial effectiveness in H. pylori gastritis. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure, Dordrecht: Kluwer Academic Publishers, 1994: 531-7.
7. Penston JG. Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
8. Reddy R, Osato M, Gutierrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the US. Gastroenterology 1996; 110: A238 (Abstract).
9. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effects of antibiotic resistance on clarithromycin combined triple therapy for Helicobacter pylori. Gut 1995; 37: A55(Abstract)
10. Yousfi MM, el-Zimaity HM, al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 209-12.
11. Moayyedi P, Sahay P, Tompkins DS, Axon AT. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-840.
12. Xia H, Daw M, Sant S, Beattie S, Keane C, O'Morain C. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993; 5: 141-4.
13. de Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20.
14. Borody T, Andrews P, Fracchia G, Brandi S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37: 477-81.
15. Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994; 25: 221-6.
16. Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-Test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996; 24: 37-41.
17. Fagan T. Quickbasic program for exact and mid-P confidence intervals for a binomial proportion. Comput Biol Med 1996; 26: 263-7.
18. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. J Am Med Assoc 1994; 272: 65-9.
19. Peura DA, Graham DY. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. Am J Gastroenlerol 1994; 89: 1137-9.
20. Graham DY. A reliable cure for Helicobacter pylori infection? Gut 1995; 37: 154-6.
21. Ferrari AP, Geocze S, Lanzoni VP, Toledo MR, Trabulsi LR, Vilela MP. Use of ampicillin plus ranitidine for Helicobacter pylori gastritis. Braz J Med Biol Res 1991; 24: 567-72.
22. Louw JA, Lucke W, Jaskiewicz K, Lastovica AJ, Winter TA, Marks IN. Helicobacter pylori eradication in the African setting. with special reference to reinfection and duodenal ulcer recurrence. Gut 1995; 36: 544-7.
23. Louw JA, Zak J, Lucke W, et al. Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates. Scand J Gastroenterol 1992; 191 (Suppl.): 28-31.
24. Hosking SW, Ling TK, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992; 305: 502-4.
25. Sung J, Leung V, Chung S, et al. Triple therapy with sucralfate, tetracydine, and metronidazole for Helicobacter pylori-associated duodenal ulcers. Am J Gastroenterol 1995; 90: 1424-7.
26. Kimura K, Ido K, Saifuku K, et al. A 1-h topical therapy for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90: 60-3.
27. Sung J, Chung S, Ling T, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
28. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 1070-5.
29. Graham DY, de Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996; 91: 1072-6.
30. Unge P, Gad A, Eriksson K, et al. Amoxycillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993; 5: 325-31.
31. Bardhan KD, Graham DY, Hunt RH, O'Morain CA. Effects of smoking on cure of H. pylori infection and duodenal ulcer recurrence in patients treated with clarithromicin and omeprazole. Helicobacter 1997, in press.
32. Dixon JS. Helicobacter pylori eradication: unravelling the fads. Scand J Gastroenlerol 1995; 212 (Suppl.): 48-62.
33. Borody TJ, Cole P, Noonan S, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431-5.
34. Coelho LG, Passos MC, Chausson Y, et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenlerol 1992; 27: 362-6.
35. Culter AF, Schubert TT. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993; 88: 1359-61.
36. Graham DY, Genta RM. Reinfection with H. pylori. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic mechanisms to clinical cure. Dordrecht: Kluwer Academic Publishers, 1994: 113-20.
37. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52.